SEC Form 4 · accession 0001209191-15-052006
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $3.59 | Jun 8, 2015 | A | 35,000 | A | — | Jun 8, 2025 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The option vests in twelve equal quarterly installments over three years from the date of grant, with the first installment vesting on September 8, 2015. The option was automatically granted pursuant to the Company's director compensation program on the date of the Company's 2015 annual meeting of stockholders at an exercise price equal to the closing price of the Company's common stock on the date of grant.